Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd
Equities
300347
CNE100001KV8
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.86 CNY | -2.98% | +1.27% | +8.90% |
04-25 | Hangzhou Tigermed Consulting’s Profit Down 59% in Q1 | MT |
04-25 | Hangzhou Tigermed Consulting Co., Ltd Reports Earnings Results for the First Quarter Ended March 30, 2024 | CI |
ETFs positioned on Hangzhou Tigermed Consulting Co., Ltd
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 1 M€ | -9.86% | - | |
0.69% | 0 M€ | -13.40% | - | |
0.18% | 35 M€ | -5.85% | - | |
0.02% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - | |
0.02% | 4 M€ | -11.56% | ||
0.01% | 0 M€ | +3.22% | - | |
0.00% | 0 M€ | +8.41% | - | |
0.00% | 0 M€ | +5.56% | - | |
0.00% | 0 M€ | +7.38% | - | |
0.00% | 0 M€ | +5.87% | - | |
0.00% | 4 M€ | -4.41% | - | |
0.00% | 0 M€ | +7.77% | - | |
0.00% | 0 M€ | +3.45% | - | |
0.00% | 0 M€ | +4.96% | - | |
0.00% | 0 M€ | +5.23% | - | |
0.00% | 0 M€ | +2.65% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.90% | 6.92B | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- 300347 Stock
- Funds and ETFs Hangzhou Tigermed Consulting Co., Ltd